Bionpharma Inc. Divalproex Sodium Delayed-Release Tablets Recall
Announced 2026-07-29 · FDA
Bionpharma Inc. is recalling Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, in 500-tablet bottles distributed nationwide in the United States. The recall is due to the presence of foreign tablets/capsules. Lot# 704C003 has expiration date 12/31/2028.
| Brand | Bionpharma Inc. |
|---|---|
| Product | Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30. |
| Reason | Presence of Foreign Tablets/Capsules |
| Severity | moderate |
| Units affected | N/A |
| Distribution | US Nationwide. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use any tablets from Lot 704C003.
- Return the product or contact Bionpharma for instructions on disposal, replacement, or refund.
- If you have taken these tablets, consult your healthcare provider if you have any concerns.
How to identify the recalled item
| Lot / date codes | Lot# 704C003, Exp. 12/31/2028 |
|---|---|
| Lot / date codes | Lot# 704C003, Exp. 12/31/2028 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
Other Bionpharma Inc. recalls
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.